The Specific Changes of Urine Raman Spectra Can Serve as Novel Diagnostic Tools for Disease Characteristics in Patients with Crohn’s Disease

References

• Danese S, Sandborn WJ, Colombel JF, et al. Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active Crohn’s disease. Gastroenterology. 2019;157(4):1007–1018.
   PubMed Web of Science ®Google Scholar
• Sands BE, Sandborn WJ, Van Assche G, et al. Vedolizumab as induction and maintenance therapy for Crohn’s disease in patients naïve to or who have failed tumor necrosis factor antagonist therapy. Inflamm Bowel Dis. 2017;23(1):97–106. doi:10.1097/MIB.0000000000000979
   PubMed Web of Science ®Google Scholar
• Wright EK, De Cruz P, Gearry R, et al. Fecal biomarkers in the diagnosis and monitoring of Crohn’s disease. Inflamm Bowel Dis. 2014;20(9):1668–1677. doi:10.1097/MIB.0000000000000087
   PubMed Web of Science ®Google Scholar
• Sands BE. Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology. 2015;149(5):1275–1285. doi:10.1053/j.gastro.2015.07.003
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Reinisch W, Colombel JF, et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial. Gut. 2014;63(1):88–95. doi:10.1136/gutjnl-2013-304984
   PubMed Web of Science ®Google Scholar
• Florin TH, Paterson EW, Fowler EV, et al. Clinically active Crohn’s disease in the presence of a low C-reactive protein. Scand J Gastroenterol. 2006;41(3):306–311. doi:10.1080/00365520500217118
   PubMed Web of Science ®Google Scholar
• Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96(3):730–734. doi:10.1111/j.1572-0241.2001.03613.x
   PubMed Web of Science ®Google Scholar
• Bonneau J, Dumestre-Perard C, Rinaudo-Gaujous M, et al. Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes. Autoimmun Rev. 2015;14(3):231–245. doi:10.1016/j.autrev.2014.11.004
   PubMed Web of Science ®Google Scholar
• Schaefer JS, Attumi T, Opekun AR, et al. MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis. BMC Immunol. 2015;16:5. doi:10.1186/s12865-015-0069-0
   PubMed Web of Science ®Google Scholar
• Larabi A, Barnich N, Nguyen HTT. Emerging role of exosomes in diagnosis and treatment of infectious and inflammatory bowel diseases. Cells. 2020;9(5):1111. doi:10.3390/cells9051111
   PubMed Web of Science ®Google Scholar
• Ayling RM, Kok K. Fecal calprotectin. Adv Clin Chem. 2018;87:161–190.
   PubMed Web of Science ®Google Scholar
• Ma C, Battat R, Parker CE, et al. Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease? Expert Rev Gastroenterol Hepatol. 2019;13(4):319–330. doi:10.1080/17474124.2019.1563481
   PubMed Web of Science ®Google Scholar
• Stanke-Labesque F, Pofelski J, Moreau-Gaudry A, et al. Urinary leukotriene E-4 excretion: a biomarker of inflammatory bowel disease activity. Inflamm Bowel Dis. 2008;14(6):769–774. doi:10.1002/ibd.20403
   PubMed Web of Science ®Google Scholar
• Bolignano D, Della Torre A, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin levels in patients with Crohn disease undergoing treatment with infliximab. J Investig Med. 2010;58(3):569–571. doi:10.2310/JIM.0b013e3181ccc20c
   PubMed Web of Science ®Google Scholar
• Sato S, Sekine R, Kagoshima H, et al. All-in-one Raman spectroscopy approach to diagnosis of colorectal cancer: analysis of spectra in the fingerprint regions. J Anus Rectum Colon. 2019;3(2):84–90. doi:10.23922/jarc.2018-039
   PubMed Web of Science ®Google Scholar
• D’Acunto M, Gaeta R, Capanna R, et al. Contribution of raman spectroscopy to diagnosis and grading of chondrogenic tumors. Sci Rep. 2020;10(1):2155. doi:10.1038/s41598-020-58848-0
   PubMed Web of Science ®Google Scholar
• Ramírez-Elías MG, González FJ. Raman spectroscopy for in vivo medical diagnosis. In: Morari Do Nascimento G, editor. Raman Spectroscopy. IntechOpen; 2018:293.
   Google Scholar
• Morasso C, Truffi M, Vanna R, et al. Raman analysis reveals biochemical differences in plasma of Crohn’s disease patients. J Crohns Colitis. 2020;14(11):1572–1580. doi:10.1093/ecco-jcc/jjaa080
   PubMed Web of Science ®Google Scholar
• Acri G, Venuti V, Costa S, et al. Raman spectroscopy as noninvasive method of diagnosis of pediatric onset inflammatory bowel disease. Appl Sci. 2020;10(19):6974. doi:10.3390/app10196974
   Google Scholar
• Bi X, Walsh A, Mahadevan-Jansen A, et al. Development of spectral markers for the discrimination of ulcerative colitis and Crohn’s disease using Raman spectroscopy. Dis Colon Rectum. 2011;54(1):48–53. doi:10.1007/DCR.0b013e3181fcf68d
   PubMed Web of Science ®Google Scholar
• Li B, Wu Y, Wang Z, et al. Non-invasive diagnosis of Crohn’s disease based on SERS combined with PCA-SVM. Anal Methods. 2021;13(44):5264–5273. doi:10.1039/D1AY01377G
   PubMed Web of Science ®Google Scholar
• Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11(1):3–25. doi:10.1093/ecco-jcc/jjw168
   PubMed Web of Science ®Google Scholar
• Pastore M, Rotondo P, Erba V, et al. Statistical learning theory of structured data. Phys Rev E. 2020;102(3–1):032119. doi:10.1103/PhysRevE.102.032119
   PubMed Web of Science ®Google Scholar
• Pence IJ, Beaulieu DB, Horst SN, et al. In vivo clinical characterization of inflammatory bowel disease with Raman spectroscopy. Biomed Opt Express. 2017;8(2):524–535. doi:10.1364/BOE.8.000524
   PubMed Web of Science ®Google Scholar
• Notingher I, Green C, Dyer C, et al. Discrimination between ricin and sulphur mustard toxicity in vitro using Raman spectroscopy. J R Soc Interface. 2004;1(1):79. doi:10.1098/rsif.2004.0008
   PubMed Web of Science ®Google Scholar
• Czamara K, Majzner K, Pacia MZ, et al. Raman spectroscopy of lipids: a review. J Raman Spectrosc. 2015;46(1):4–20. doi:10.1002/jrs.4607
   Web of Science ®Google Scholar
• Stone N, Kendall C, Smith J, et al. Raman spectroscopy for identification of epithelial cancers. Faraday Discuss. 2004;126:141–157. doi:10.1039/b304992b
   PubMed Web of Science ®Google Scholar
• Talari ACS, Movasaghi Z, Rehman S, et al. Raman spectroscopy of biological tissues. Appl Spectr Rev. 2015;50:46–111. doi:10.1080/05704928.2014.923902
   Web of Science ®Google Scholar
• Mahadevan-Jansen A, Richards-Kortum R. Raman spectroscopy for the detection of cancers and precancers. J Biomed Opt. 1996;1(1):31–70. doi:10.1117/12.227815
   PubMedGoogle Scholar
• De Gelder J, De Gussem K, Vandenabeele P, et al. Reference database of Raman spectra of biological molecules. J Raman Spectrosc. 2007;38:1133–1147. doi:10.1002/jrs.1734
   Web of Science ®Google Scholar
• Vanna R, Ronchi P, Lenferink ATM, et al. Label-free imaging and identification of typical cells of acute myeloid leukaemia and myelodysplastic syndrome by Raman microspectroscopy. Analyst. 2015;140(4):1054–1064. doi:10.1039/C4AN02127D
   PubMed Web of Science ®Google Scholar
• Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006;101(10):2410–2422. doi:10.1111/j.1572-0241.2006.00840.x
   PubMed Web of Science ®Google Scholar
• Prideaux L, De Cruz P, Ng SC, et al. Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2012;18(7):1340–1355. doi:10.1002/ibd.21903
   PubMed Web of Science ®Google Scholar
• Bielecki C, Bocklitz TW, Schmitt M, et al. Classification of inflammatory bowel diseases by means of Raman spectroscopic imaging of epithelium cells. J Biomed Opt. 2012;17(7):076030. doi:10.1117/1.JBO.17.7.076030
   PubMed Web of Science ®Google Scholar
• Tefas C, Mărginean R, Toma V, et al. Surface-enhanced Raman scattering for the diagnosis of ulcerative colitis: will it change the rules of the game? Anal Bioanal Chem. 2021;413(3):827–838. doi:10.1007/s00216-020-03036-2
   PubMed Web of Science ®Google Scholar
• Li X, Li X. Obesity promotes experimental colitis by increasing oxidative stress and mitochondrial dysfunction in the colon. Inflammation. 2020;43(5):1884–1892. doi:10.1007/s10753-020-01261-6
   PubMed Web of Science ®Google Scholar
• Atreya R, Siegmund B. Location is important: differentiation between ileal and colonic Crohn’s disease. Nat Rev Gastroenterol Hepatol. 2021;18(8):544–558. doi:10.1038/s41575-021-00424-6
   PubMed Web of Science ®Google Scholar
• D’Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2218–2224. doi:10.1002/ibd.22917
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Chaparro M. Predictors of primary response to biologic treatment [anti-TNF, vedolizumab, and ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice. J Crohns Colitis. 2020;14(5):694–709. doi:10.1093/ecco-jcc/jjz195
   PubMed Web of Science ®Google Scholar
• Ruemmele FM. Role of diet in inflammatory bowel disease. Ann Nutr Metab. 2016;68(Suppl 1):S33–S41. doi:10.1159/000445392
   PubMed Web of Science ®Google Scholar